1. Home
  2. AQST vs PMO Comparison

AQST vs PMO Comparison

Compare AQST & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • PMO
  • Stock Information
  • Founded
  • AQST 2004
  • PMO 1993
  • Country
  • AQST United States
  • PMO United States
  • Employees
  • AQST N/A
  • PMO N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • PMO Finance Companies
  • Sector
  • AQST Health Care
  • PMO Finance
  • Exchange
  • AQST Nasdaq
  • PMO Nasdaq
  • Market Cap
  • AQST 254.1M
  • PMO 287.4M
  • IPO Year
  • AQST 2018
  • PMO N/A
  • Fundamental
  • Price
  • AQST $2.79
  • PMO $10.00
  • Analyst Decision
  • AQST Strong Buy
  • PMO
  • Analyst Count
  • AQST 5
  • PMO 0
  • Target Price
  • AQST $11.40
  • PMO N/A
  • AVG Volume (30 Days)
  • AQST 939.1K
  • PMO 99.0K
  • Earning Date
  • AQST 05-12-2025
  • PMO 01-01-0001
  • Dividend Yield
  • AQST N/A
  • PMO 4.10%
  • EPS Growth
  • AQST N/A
  • PMO N/A
  • EPS
  • AQST N/A
  • PMO 0.42
  • Revenue
  • AQST $57,561,000.00
  • PMO N/A
  • Revenue This Year
  • AQST N/A
  • PMO N/A
  • Revenue Next Year
  • AQST $39.51
  • PMO N/A
  • P/E Ratio
  • AQST N/A
  • PMO $24.38
  • Revenue Growth
  • AQST 13.79
  • PMO N/A
  • 52 Week Low
  • AQST $2.20
  • PMO $8.57
  • 52 Week High
  • AQST $5.80
  • PMO $10.68
  • Technical
  • Relative Strength Index (RSI)
  • AQST 49.93
  • PMO 54.55
  • Support Level
  • AQST $2.59
  • PMO $9.84
  • Resistance Level
  • AQST $3.05
  • PMO $10.04
  • Average True Range (ATR)
  • AQST 0.16
  • PMO 0.10
  • MACD
  • AQST 0.00
  • PMO 0.04
  • Stochastic Oscillator
  • AQST 43.57
  • PMO 91.30

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About PMO Putnam Municipal Opportunities Trust

Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.

Share on Social Networks: